$RDHL

$0.41▲ +5.1% YTD

8 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

RDHL ▲ +5.1% - RedHill Biopharma Ltd.

CP $0.41▲ +5.1%Nov 2, 2026 · ThinkSabio Blog

$RDHL RDHL RDHL - Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate…

News

RDHL ▲ +4.2% - RedHill Biopharma Ltd.

CP $0.50▲ +4.2%Oct 19, 2026 · ThinkSabio Blog

$RDHL RDHL RDHL - $2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple…

News

RDHL ▼ -2.1% - RedHill Biopharma Ltd.

CP $0.47▲ -2.1%Sep 30, 2026 · ThinkSabio Blog

$RDHL RDHL RDHL - RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results…

News

RDHL ▼ -2.2% - RedHill Biopharma Ltd.

CP $0.90▲ -2.2%Sep 1, 2026 · ThinkSabio Blog

$RDHL - RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®…

News

RDHL ▼ -2.2% - RedHill Biopharma Ltd.

CP $0.90▲ -2.2%Sep 1, 2026 · ThinkSabio Blog

$RDHL RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®…

News

RDHL ▼ -4.3% - RedHill Biopharma Ltd.

CP $0.88▲ -4.3%Sep 1, 2026 · ThinkSabio Blog

$RDHL RDHL RDHL - RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®…

News

RDHL ▲ +116.7% - RedHill Biopharma Ltd.

CP $1.43▲ +116.7%Aug 31, 2026 · ThinkSabio Blog

$RDHL trading…

News

RDHL ▼ -4.5% - RedHill Biopharma Ltd.

CP $0.63▲ -4.5%Aug 31, 2026 · ThinkSabio Blog

$RDHL RDHL - RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities…